TransMedics Group, Inc. (TMDX): Net Income

Annual figures by period end, from SEC filings.

$190.29M

Year ended 2025-12-31

$151.70M

Trailing 12 months to 2026-06-30

2018-12-29 Net Income (USD) 2025-12-31

Period ended	Net Income	Change YoY	Source filing
2025-12-31	$190.29M	+436.6%	2026-02-24, From 2025-01-01
2024-12-31	$35.46M	n/m	2026-02-24, From 2024-01-01
2023-12-31	-$25.03M	n/m	2026-02-24, From 2023-01-01
2022-12-31	-$36.23M	n/m	2025-02-27, From 2022-01-01
2021-12-31	-$44.22M	n/m	2024-02-27, From 2021-01-01
2020-12-31	-$28.75M	n/m	2023-02-27, From 2019-12-29
2019-12-28	-$33.55M	n/m	2021-03-11, From 2018-12-30
2018-12-29	-$23.76M	n/a	2020-03-17, From 2017-12-31

Net Income at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Net Income	Change YoY
TransMedics Group, Inc. (TMDX)	2025-12-31	$190.29M	+436.6%
InMode Ltd. (INMD)	2025-12-31	$93.83M	-48.2%
Conmed Corp (CNMD)	2025-12-31	$47.05M	-64.5%
LivaNova PLC (LIVN)	2025-12-31	-$242.47M	n/m
Axogen, Inc. (AXGN)	2025-12-31	-$15.70M	n/m
Integer Holdings Corp (ITGR)	2025-12-31	$102.81M	-14.3%
Outset Medical, Inc. (OM)	2025-12-31	-$81.65M	n/m
Biolife Solutions Inc (BLFS)	2025-12-31	-$4.59M	n/m
Vaso Corp (VASO)	2025-12-31	$1.57M	+65.0%

Compare TMDX, INMD, CNMD, LIVN side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗